Patents Assigned to Imugene Limited
  • Vaccine composition and uses thereof
    Patent number: 12311019
    Abstract: Disclosed herein is a vaccine composition for raising a humoral response to PD1, and uses thereof, for treating a cancer characterised by an involvement of PD1, wherein the vaccine composition comprises an effective amount of an immunogen that induces an antibody response in which the antibody binds to a B cell epitope of PD1.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: May 27, 2025
    Assignee: Imugene Limited
    Inventors: Nicholas Ede, Ursula Wiedermann, Joshua Tobias, Christoph Zielinski
  • Methods and Compositions for Increasing Tissue Tropism of Recombinant Adenoviral Vectors
    Publication number: 20100104600
    Abstract: Methods are provide to allow for the preparation of adenoviral vectors with altered tropism. Compositions comprising such vectors and methods of use thereof also are provided.
    Type: Application
    Filed: July 27, 2007
    Publication date: April 29, 2010
    Applicants: Commonwealth Scientific and Industrial Research Organisation, Imugene Limited
    Inventors: Jeffrey Hammond, Michael A. Johnson